Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cenplacel-L in patients with moderate-to-severe Crohn's disease

Trial Profile

Cenplacel-L in patients with moderate-to-severe Crohn's disease

Phase of Trial: Phase I/II

Latest Information Update: 01 Aug 2015

At a glance

  • Drugs Cenplacel L (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2012 New trial record
    • 24 Oct 2012 Results presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology.
    • 01 Oct 2012 Primary endpoint 'Clinical-response-rate' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top